Clinical Trials Logo

Clinical Trial Summary

The investigators hypothesize that combined treatment with the GLP-1R agonist semaglutide 2.4 mg and levonorgestrel intrauterine device (LNG-IUD), compared to LNG-IUD alone, will result in improved likelihood of uterine preservation, sustained weight loss, improved endometrial and metabolomic response to progestin, and improved quality of life in premenopausal women with endometrial hyperplasia who desire uterine preservation.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05829460
Study type Interventional
Source Washington University School of Medicine
Contact Andrea R Hagemann, M.D., MSCI
Phone 314-362-1763
Email hagemanna@wustl.edu
Status Not yet recruiting
Phase Phase 2
Start date June 30, 2024
Completion date June 30, 2031

See also
  Status Clinical Trial Phase
Completed NCT05378152 - Assessing the Benefit of Pipelle Biopsy in Patients With Postmenopausal Bleeding and an Atrophic-appearing Cavity N/A
Withdrawn NCT00123175 - Treatment of Endometrial Hyperplasia With an Intrauterine Device (IUD) Phase 1/Phase 2
Completed NCT02100137 - Women With Asymptomatic Endometrial Hyperplasia N/A
Completed NCT00242710 - Study Evaluating Bazedoxifene/Conjugated Estrogens Combinations In Postmenopausal Women Phase 3
Not yet recruiting NCT04191603 - TWO DÄ°FFERENT ELECTROSURGERY DEVICES AS MONOPOLAR HOOC AND PLASMAKINETIC BIPOLAR SPATULA EFFECTIVENESS DURING COLPOTOMY N/A
Completed NCT03032848 - Vaginal Estrogens Comparative Trial on Pelvic Organ Prolapse Patients Phase 4
Completed NCT00339651 - Preliminary Study of Endometrial Hyperplasia Groundwork for a Study to Define Precursors of Endometrial Cancer
Recruiting NCT01234818 - Management of Endometrial Hyperplasia With a LNG-IUS: Multicenter Study: KGOG2006 Phase 2
Recruiting NCT04362046 - Fertility Sparing Management of EndomeTrial Cancer and Hyperplasia N/A
Active, not recruiting NCT05257057 - Frequency of Endometrial Cancer Precursors Associated With Lynch Syndrome
Completed NCT01499602 - Efficacy of LNG-IUS for Treatment of Non-atypical Endometrial Hyperplasia in Perimenopausal Women N/A
Completed NCT00883662 - Mirena Observational Program N/A
Completed NCT01074892 - A Study Comparing Mirena and Systemic Progestin for Endometrial Hyperplasia Phase 4
Not yet recruiting NCT05903131 - A Behavioral Intervention to Promote Primary Prevention and Uterine Preservation in Premenopausal Women With Obesity and Endometrial Hyperplasia Phase 2
Withdrawn NCT04897217 - Levonorgestrel-Releasing Intrauterine System (LNG-IUS) in the Management of Atypical Endometrial Hyperplasia Phase 3
Recruiting NCT03176992 - Surgicel® & Endometrial Ablation in the Management of Perimenpausal Heavy Menstrual Bleeding Phase 2
Not yet recruiting NCT00919919 - Efficacy and Tolerability Study of Progesterone Vaginal Tablets (Endometrin®) in Menopausal Women Treated by Estrogen Phase 2
Recruiting NCT03207126 - Pilot Study: Can Ultrasound Guided Biopsy be Used as an Alternative to Hysteroscopy? N/A
Recruiting NCT03207061 - Can 3D Ultrasound be Used as an Alternative to MRI to Assess Myometrial Invasion in Endometrial Cancer? N/A
Completed NCT03207074 - Can the iKnife Distinguish Between Normal and Malignant Endometrial Tissue? N/A